S. Muller

Empiric therapy with moxalactam alone in patients with bacteremia.

J. Rosenblatt, F. Cockerill, T. Keys, 1984, Mayo Clinic proceedings.

V(D)J recombination defects in lymphocytes due to RAG mutations: severe immunodeficiency with a spectrum of clinical presentations.

E. Brooks, K. Schwarz, A. Villa, 2001, Blood.

Bacteremia due to Stenotrophomonas (Xanthomonas) maltophilia: a prospective, multicenter study of 91 episodes.

K. Papadakis, M. Edmond, J. Chow, 1996, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Epidemiology and Clinical Presentation of Children Hospitalized with SARS-CoV-2 Infection in Suburbs of Paris

N. Garrec, R. Epaud, E. Varon, 2020, Journal of clinical medicine.

Ciprofloxacin versus trimethoprim-sulfamethoxazole: treatment of community-acquired urinary tract infections in a prospective, controlled, double-blind comparison.

D. Ilstrup, W. Wilson, N. Henry, 1992, Mayo Clinic proceedings.

Epidemiology and Clinical Presentation of Children Hospitalized with SARS-CoV-2 Infection in Suburbs of Paris

N. Garrec, R. Epaud, E. Varon, 2020, Journal of clinical medicine.

Prospective randomized comparison of mezlocillin therapy alone with combined ampicillin and gentamicin therapy for patients with cholangitis.

N. LaRusso, J. Rosenblatt, W. Wilson, 1989, Archives of internal medicine.

Renal toxicity during therapy with gentamicin or tobramycin.

T. Keys, S. Kurtz, J. D. Jones, 1981, Mayo Clinic proceedings.

Comparison of ciprofloxacin and co-trimoxazole in the treatment of uncomplicated urinary tract infection in women.

D. Ilstrup, W. Wilson, N. Henry, 1986, The Journal of antimicrobial chemotherapy.

Metabolism and metronidazole uptake in Trichomonas vaginalis isolates with different metronidazole susceptibilities

M. Müller, T. Gorrell, S. Muller, 1983, Antimicrobial Agents and Chemotherapy.